A mutant strain deficient in RNase T was isolated and used to study the role of this enzyme in Escherichia coli. Strains lacking as much as 70% of RNase T activity, alone or in combination with the absence of other RNases, display normal growth properties. However, in cca strains, which lack tRNA nucleotidyltransferase, RNase T-deficient derivatives accumulate lower levels of defective tRNA and grow at increased rates compared to their RNase T' parents. Slow-growing cca strains revert to a faster-growing form that contains less defective tRNA but which is still cca. All of these strains have decreased levels of RNase T. These data indicate that RNase T is responsible for nucleotide removal during the tRNA end-turnover process and that the amount of defective tRNA in cells is determined by the relative levels of RNase T and tRNA nucleotidyltransferase.
growing cca strains revert to a faster-growing form that contains less defective tRNA but which is still cca. All of these strains have decreased levels of RNase T. These data indicate that RNase T is responsible for nucleotide removal during the tRNA end-turnover process and that the amount of defective tRNA in cells is determined by the relative levels of RNase T and tRNA nucleotidyltransferase.
The end-turnover of tRNA has been known since the earliest studies of tRNA metabolism (1). The process consists of the removal and readdition of the 3' terminal AMP and penultimate CMP residues of tRNA. Although the physiological function, if any, of end-turnover is unclear, it is known to involve tRNAs for only some amino acids and to require uncharged tRNA (2). Furthermore, if the readdition of missing terminal residues is prevented, defective tRNA molecules accumulate (3), leading to a considerable slowdown of growth of Escherichia coli and the elevation of guanosine 3'-diphosphate 5'-diphosphate (ppGpp) levels (4) .
It has been known for a number of years, through the use of E. coli mutants, that the readdition phase of the turnover process requires the enzyme tRNA nucleotidyltransferase (2). However, the enzyme responsible for removal of the terminal residues was unknown. Since tRNA nucleotidyltransferase is simply a scavenger of incomplete tRNA molecules and is present in large excess in cells, the repair of defective tRNA appears to be unregulated. Thus, any control of the turnover process would be at the level of nucleotide removal. To understand this process more fully, identification and study of the enzyme required for nucleotide removal is a necessary prerequisite.
We have recently described a previously unidentified E. coli exoribonuclease, RNase T, whose in vitro specificity suggested that it might be the nuclease involved in endturnover (5) . RNase T has been purified to homogeneity (6) . It is an a2 dimer with a molecular weight of 50,000 (6) . The enzyme is highly specific for tRNA-C-C-A, releasing AMP and tRNA-C-C (5). RNase T initiates attack at a free 3' terminus of tRNA; aminoacyl-tRNA is not a substrate (6) . In this paper we describe the isolation of an E. coli mutant deficient in RNase T. Studies of the mutant have provided direct evidence that this enzyme is responsible for nucleotide removal during the end-turnover process.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions. Wild-type E. coli strain CA265, its RNase-derivative strains CAN, CAN/20, and CAN/20-12, and the multiple RNase-deficient derivative CAN/20-12E have been described (5, 7) . The RNase Tdeficient strains 20-12E/18 and 20-12E/18-11 were isolated as described below. cca derivatives of the various strains, lacking tRNA nucleotidyltransferase, were constructed by bacteriophage P1-mediated transduction of the cca locus from strain 35-10, using toIC as the selectable marker as described (8) . Cells were grown in YT medium containing 0.4% glucose (9) . Tetracycline-resistant strains were routinely grown in the presence of tetracycline (10 jug/ml).
Mutagenesis and Screening of Mutants. Strain CAN/20-12E was grown to an OD550 of 1 in YT medium containing tetracycline and then was mutagenized with nitrosoguanidine (0.5 mg/ml) for 30 min at 370C as described (10) . Survival after this procedure was about 2%. The mutagenized culture was divided into 30 portions, diluted with fresh YT medium, and grown overnight at 30°C. Cells from each stock tube were plated on YT agar, grown at 30°C overnight, and then transferred to 42°C for 8-16 hr. Small colonies were picked and retested for temperature-sensitive growth. One-hundred twenty-six temperature-sensitive colonies were obtained by this procedure. The colonies displaying temperature-sensitive growth were screened for RNase T activity.
Identification of colonies containing decreased RNase T activity was accomplished by assaying extracts for their ability to hydrolyze tRNA-C-C-[14C]A. Cells were grown in YT medium to an OD550 of 1 at 30°C, centrifuged, resuspended in one-fourth volume of 20 mM glycine/NaOH, pH 8.9/0.1 mM EDTA/1 mM dithiothreitol, and sonicated for 30 sec. After centrifugation to remove cell debris, 100-,l aliquots were incubated for 2 min at 37°C and then assayed for RNase T activity for 30 min at 30°C in 200-,u1 reaction mixtures containing 20 mM glycine/NaOH (pH 8.9), 5 mM MgCl2, and 30 ,tg of tRNA-C-C-[14C]A.
The RNase T mutant strain 20-12E/18 was converted to one with temperature-insensitive growth by P1 transduction, followed by selection for cells able to grow at 44°C. The resulting derivative strain, which retained its RNase T deficiency, was termed 20-12E/18-11.
Other Materials. tRNA was isolated from E. coli by phenol extraction and isopropanol fractionation as described (3) . 
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RESULTS
Isolation of a RNase T-Deficient Mutant Strain. By using a "brute-force" isolation procedure to assay colonies from a heavily mutagenized stock ofCAN/20-12E, we identified one RNase T-deficient strain among 126 independent, temperature-sensitive colonies tested. Extracts of this strain, 20-12E/18, contained about 30% the normal level of RNase [14C]AMP incorporation into 100 ,ug was determined with purified tRNA nucleotidyltransferase as described (5) . CAN data were taken from ref. 5. T activity (Table 1) . Partial purification of RNase T from mutant and parental strains by Ultrogel AcA 44 and DEAESephadex chromatography revealed that both showed similar chromatographic properties; however, the enzyme from the mutant strain was more temperature-sensitive and had a slightly higher Km for the tRNA substrate (data not shown), suggesting that the mutation is in the structural gene for RNase T. Since RNase T is the only nuclease in extracts of strain CAN/20-12E that is active on tRNA-C-C-A, the 70% decrease in activity in the mutant strain must be due to an effect on this enzyme.
To (5) , indicating that these RNases do not play a role in end-turnover. Furthermore, as shown in Table 2 , a cca derivative of the multiple RNase-deficient strain, CAN-20/12E (RNase I-,II-,D-, BN-), has the normal amount of defective tRNA. These data indicate that of the known exoribonucleases, only RNase T participates in the end-turnover of tRNA in vivo.
Growth of RNase T-/cca Double Mutants. Strains containing a cca mutation grow slowly (12); likewise, cca double mutants lacking either RNase BN; RNases II, D, and BN; or RNases I, II, D, and BN also grow slowly (Fig. 1) . In contrast, a RNase T-/cca double mutant is able to grow much more rapidly (Fig. 1) , demonstrating that the slowgrowth phenotype is a consequence of the presence of RNase T. It has been shown previously that the growth rate of cca strains is inversely dependent on their level of defective tRNA (4, 12) . Thus, the more rapid growth of RNase Tstrains, which contain less defective tRNA (Table 2) , is entirely consistent with this earlier finding.
Fast-Growing cca Strains Are RNase T-. Slow-growing cca strains often revert to a faster-growing form that remains cca but which contains only about half as much defective tRNA as the original strain (4, 12) . The data presented here suggest that these revertant strains may have become RNase T-. If this idea is correct, the reversion of cca strains to faster growth might provide a way to select for RNase T-mutants. To test this possibility, cca derivatives of the wild type strain CA265 and the multiple RNase-deficient strain, CAN/20-12E were grown to stationary phase to allow enrichment for faster-growing cells. Individual cultures were diluted, regrown, and plated, and the largest colonies were tested for RNase T and tRNA nucleotidyltransferase activity (Table 3 ). In the case of strain CA265 cca, all large colonies tested (18 of 18) displayed decreased levels of RNase T that varied from 26 to 73% of the activity in strain CA265. In addition, all the strains tested remained cca. Likewise, of 24 large CAN/20-12E cca colonies tested, all showed decreased RNase T activity, amounting to 52 to 76% of the activity of CAN/20-12E (Table 3) . Taken together, these findings indicate that the slow growth of cca cells is due to the accumulation of defective tRNA and that the defect can be eliminated to a large extent by decreasing the activity of RNase T.
Although the RNase T-, cca revertants grow much more rapidly than RNase T+/cca cells (--40 min versus -150 min doubling time), these cells still grow somewhat more slowly than their cca+ counterparts (doubling time --30 min). The large difference in growth rates between RNase T-/cca and RNase T+/cca cells, however, makes it extremely difficult to maintain liquid cultures of the slow-growing cells since fast-growing revertants rapidly take over.
DISCUSSION
The data presented here provide evidence that RNase T is the ribonuclease responsible for the end-turnover of tRNA. However, this role for RNase T only becomes evident in cca genetic backgrounds. In the absence of tRNA nucleotidyltransferase, RNase T-deficient strains accumulate less defective tRNA and grow at increased rates. In cca+ strains the absence of as much as 70% the usual amount of RNase T has no effect on the growth properties of a wild-type strain or of one lacking RNases I, II, D, and BN. The apparent dispensability of these RNases remains to be explained. It strongly suggests that additional exoribonucleases must be present in E. coli that compensate for the ones that are missing, but the reason for the high degree of redundancy among the exoribonucleases is not clear.
The amount of defective tRNA in cells is a consequence of the relative levels of RNase T and tRNA nucleotidyltransferase. Under normal circumstances, the amount of tRNA nucleotidyltransferase in cells is sufficient to maintain all tRNAs in an intact form. However, in cca mutants the effect of RNase T predominates. It is known that end-turnover only affects uncharged tRNAs in vivo and leads to removal primarily of the 3' terminal AMP residue. The properties of RNase T in vitro conform exactly to these restraints: we have recently shown that aminoacyl-tRNA and tRNA-C-C are relatively inactive as substrates for this enzyme (5, 6) .
The physiological significance of end-turnover and the role of RNase T are not understood. At first glance the process appears to be a futile cycle. However, the existence of a highly specific ribonuclease that removes only the 3' terminal AMP of tRNA raises questions about whether the turnover process does have some importance. The presence of a similar activity in Xenopus oocytes (13) and in rat liver (unpublished observation) supports this possibility. Further studies of RNase T mutants should help to resolve this issue.
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